Hillhouse Investment Management, Ltd. sold $13M of AVBP
owner at ArriVent BioPharma, Inc.. 555,555 shares at an average of $23.37, traded Dec 10, 2025, filed Feb 3, 2026.
Score components
- +12Role10% owner
- +25Trade size$13.0M at market
- +5Share of holdings soldSold 12% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000902664-26-000675, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -555,555 | $23.37 | $13M | 3,929,117 | Feb 3, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.